Route Utilisation Strategy

"Energy Transition Towards a Net Zero World" - 16th Singapore International Energy Week

Retrieved on: 
Friday, April 28, 2023

"This year's theme, Energy Transition towards a Net Zero World, will explore how we can enhance and co-create pathways for Asia and the world to accelerate the transition towards a net zero energy future.

Key Points: 
  • "This year's theme, Energy Transition towards a Net Zero World, will explore how we can enhance and co-create pathways for Asia and the world to accelerate the transition towards a net zero energy future.
  • Governments, multilateral institutions, and industry leaders must continue to deepen regional and international collaboration to support the energy transition, especially in Southeast Asia," said Ngiam Shih Chun, Chief Executive of EMA.
  • SIEW Energy Insights, SIEW TechTable and SIEW Thinktank Roundtables will showcase insights about the emerging energy trends, latest products and solutions, and in-depth discussions on key energy issues.
  • SIEW will partner with the International Energy Agency and the International Renewable Energy Agency again to co-host high-level events that examine areas such as energy security, sustainable financing and policy levers for a just and inclusive energy transition.

Back-to-back Studies Validate geneType Breast Cancer Risk Test

Retrieved on: 
Monday, March 13, 2023

geneType Breast Cancer Risk Assessment Test demonstrated improved performance compared to a gold-standard model (BCRAT) over a 5-year period.

Key Points: 
  • geneType Breast Cancer Risk Assessment Test demonstrated improved performance compared to a gold-standard model (BCRAT) over a 5-year period.
  • The study showed that geneType not only put more women into an increased risk category but also demonstrated women in this category developed breast cancer at a higher incidence.
  • This study is the third paper accepted for publication in the last six months that highlights the utility of the geneType Breast Cancer Risk Assessment Test as powerful risk stratification tool available to the general population.
  • GeneType improved discrimination and risk categorization when compared to one of the most well-known models, the Breast Cancer Risk Assessment Tool (BCRAT).